These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 15385935

  • 1. CPEC induces erythroid differentiation of human myeloid leukemia K562 cells through CTP depletion and p38 MAP kinase.
    Huang M, Wang Y, Collins M, Graves LM.
    Leukemia; 2004 Nov; 18(11):1857-63. PubMed ID: 15385935
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Activin A induces erythroid gene expressions and inhibits mitogenic cytokine-mediated K562 colony formation by activating p38 MAPK.
    Huang HM, Chiou HY, Chang JL.
    J Cell Biochem; 2006 Jul 01; 98(4):789-97. PubMed ID: 16440334
    [Abstract] [Full Text] [Related]

  • 4. Resistance to cyclopentenylcytosine in murine leukemia L1210 cells.
    Zhang H, Cooney DA, Zhang MH, Ahluwalia G, Ford H, Johns DG.
    Cancer Res; 1993 Dec 01; 53(23):5714-20. PubMed ID: 7694793
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Cyclosporin A induces erythroid differentiation of K562 cells through p38 MAPK and ERK pathways.
    Sawafuji K, Miyakawa Y, Kizaki M, Ikeda Y.
    Am J Hematol; 2003 Jan 01; 72(1):67-9. PubMed ID: 12508271
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Reversal by cytidine of cyclopentenyl cytosine-induced toxicity in mice without compromise of antitumor activity.
    Ford H, Driscoll JS, Hao Z, Dobyns KA, Rommel ME, Stowe E, Anderson JO, Plowman J, Waud WR, Johns DG.
    Biochem Pharmacol; 1995 Jan 18; 49(2):173-80. PubMed ID: 7840794
    [Abstract] [Full Text] [Related]

  • 15. Antiproliferative effects of cyclopentenyl cytosine (NSC 375575) in human glioblastoma cells.
    Agbaria R, Kelley JA, Jackman J, Viola JJ, Ram Z, Oldfield E, Johns DG.
    Oncol Res; 1997 Jan 18; 9(3):111-8. PubMed ID: 9220496
    [Abstract] [Full Text] [Related]

  • 16. Cyclopentenyl cytosine induces senescence in breast cancer cells through the nucleolar stress response and activation of p53.
    Huang M, Whang P, Lewicki P, Mitchell BS.
    Mol Pharmacol; 2011 Jul 18; 80(1):40-8. PubMed ID: 21464199
    [Abstract] [Full Text] [Related]

  • 17. Different roles of p38 MAPK and ERK in STI571-induced multi-lineage differentiation of K562 cells.
    Kohmura K, Miyakawa Y, Kawai Y, Ikeda Y, Kizaki M.
    J Cell Physiol; 2004 Mar 18; 198(3):370-6. PubMed ID: 14755542
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Ectopic cyclin D1 expression blocks STI571-induced erythroid differentiation of K562 cells.
    Kawano T, Horiguchi-Yamada J, Saito S, Iwase S, Furukawa Y, Kano Y, Yamada H.
    Leuk Res; 2004 Jun 18; 28(6):623-9. PubMed ID: 15120940
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.